Want to join the conversation?
$RSG's 3Q15 EBITDA margin was 28.1%, which was consistent with the prior year. YTD, EBITDA margin was 28.4%, which is in line with its full year guidance. Core price during the quarter was 3.6% and average yield was 2.5%. The sequential increase in yield performance reflects an improvement in the level of churn.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?